For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Easyhaler (Budesonide) - Asthma
PAD Profile : Easyhaler (Budesonide) - Asthma
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Fostair NEXThaler (beclometasone and formoterol)
- Montelukast
- Theophylline
- Easyhaler (Salbutamol)
- Clenil Modulite (beclometasone)
- Easyhaler (Beclometasone)
- Fostair (Beclometasone and formoterol)
- Budelin Novolizer (budesonide)
- Dupilumab
- Airflusal (Salmeterol/Fluticasone) MDI
- Aerivio Spiromax (Fluticasone/Salmeterol) DPI
- Ventolin Accuhaler (salbutamol)
- Sereflo Ciphaler (Salmeterol / Fluticasone) DPI
- Campona Airmaster (Salmeterol / Fluticasone) DPI
- Salbutamol
- Terbutaline sulphate
- Budesonide
- Salamol Easi-Breathe
Other Indications
- Allergic rhinitis
- Inflammatory bowel disease
- Asthma
- Oesophagitis (inducing remission)
- Oesophagitis (maintenance)
- Covid-19
- Nephropathy
- Asthma
- Bronchopulmonary dysplasia
- Nasal polyps
Additional Documents
Committee Recommendations
Budesonide Easyhaler may be considered in patients aged 12-17 if these other preferred, licensed devices are not suitable:
Clenil Modulite (beclometasone MDI) plus spacer (Volumatic, Able Spacer, Optichamber) or Qvar (beclometasone MDI) plus spacer (Aerochamber plus, Able Spacer, Optichamber) are the locally agreed preferred ICS devices.
If a breath activated device is necessary, consider:
Easyhaler Beclometasone (breath activated) DPI
Qvar Easi-Breathe (breath activated) MDI
Prescribe inhaler devices by BRAND to ensure consistency and avoid confusion
The guidelines for asthma can be found below